Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days

A

AKTX

Akari Therapeutics Plc ADR

11.47

Sep 04 • 3:57 PM ET +0.63 (5.81%)

11.89

Aftermarket • 7:42 PM ET +0.41 (3.62%)

Healthcare Biotechnology USA Nano NASD

Peers: IKT NBP NERV NVCT ALXO BCYC CGEN FATE FHTX CDXS

Scroll to Statements

Index	-
Market Cap	20.07M
Enterprise Value	13.01M
Income	-30.90M
Sales	0.00M
Book/sh	10.62
Cash/sh	4.43
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	6
IPO	May 07, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.08
P/C	2.59
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.60
Current Ratio	0.60
Debt/Eq	0.04
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-17.25
EPS next Y	-2.33
EPS next Q	-2.09
EPS this Y	48.40%
EPS next Y	78.16%
EPS next 5Y	46.65%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	1.39%
Sales Q/Q	-
Earnings	Aug 13 AMC
EPS/Sales Surpr.	100.00% -

Insider Own	0.40%
Insider Trans	0.00%
Inst Own	8.61%
Inst Trans	-16.26%
ROA	-69.02%
ROE	-139.80%
ROIC	-166.16%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	32.33%
SMA50	19.43%
SMA200	15.73%
Trades

Shs Outstand	1.75M
Shs Float	1.74M
Short Float	2.16%
Short Ratio	0.53
Short Interest	0.04M
52W High	49.60 -76.87%
52W Low	3.02 280.43%
Volatility	14.17% 12.30%
ATR (14)	1.18
RSI (14)	67.17
Beta	1.43
Rel Volume	1.55
Avg Volume	70.43K
Volume	108,905

Perf Week	7.20%
Perf Month	41.96%
Perf Quarter	-23.89%
Perf Half Y	14.15%
Perf YTD	-0.78%
Perf Year	-60.72%
Perf 3Y	-91.41%
Perf 5Y	-99.22%
Perf 10Y	-99.84%
Recom	1.00
Target Price	28.50
Prev Close	10.84
Price	11.47
Change %	5.81%

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)